Complement Component C3 Binds to Activated Normal Platelets without Preceding Proteolytic Activation and Promotes Binding to Complement Receptor 1

per Hamad, Osama A., Nilsson, Per H., Wouters, Diana, Lambris, John D., Ekdahl, Kristina N., Nilsson, Bo
Publicat 2010

Contribution of Chondroitin Sulfate A to the Binding of Complement Proteins to Activated Platelets

per Hamad, Osama A., Nilsson, Per H., Lasaosa, Maria, Ricklin, Daniel, Lambris, John D., Nilsson, Bo, Nilsson Ekdahl, Kristina
Publicat 2010

Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18

per Hamad, Osama A., Mitroulis, Ioannis, Fromell, Karin, Kozarcanin, Huda, Chavakis, Triantafyllos, Ricklin, Daniel, Lambris, John D., Ekdahl, Kristina N., Nilsson, Bo
Publicat a Thromb Haemost (2015)

Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles

per Klapper, Yvonne, Hamad, Osama A., Teramura, Yuji, Leneweit, Gero, Nienhaus, G. Ulrich, Ricklin, Daniel, Lambris, John D., Ekdahl, Kristina N., Nilsson, Bo
Publicat 2014

Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?

per Moll, Guido, Hult, Annika, von Bahr, Lena, Alm, Jessica J., Heldring, Nina, Hamad, Osama A., Stenbeck-Funke, Lillemor, Larsson, Stella, Teramura, Yuji, Roelofs, Helene, Nilsson, Bo, Fibbe, Willem E., Olsson, Martin L., Le Blanc, Katarina
Publicat 2014

Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?

per Moll, Guido, Alm, Jessica J., Davies, Lindsay C., von Bahr, Lena, Heldring, Nina, Stenbeck-Funke, Lillemor, Hamad, Osama A., Hinsch, Robin, Ignatowicz, Lech, Locke, Matthew, Lönnies, Helena, Lambris, John D., Teramura, Yuji, Nilsson-Ekdahl, Kristina, Nilsson, Bo, Le Blanc, Katarina
Publicat a Stem Cells (2014)